Existing antilisterial immunity does not inhibit the development of a Listeria monocytogenes-specific primary cytotoxic T-lymphocyte response

Infection and Immunity

Volumn 67, Issue 1, 1999, Pages 253-258

  Bouwer, H G Archie ^a   Shen, Hao ^b   Fan, Xin ^b   Miller, Jeff F ^c   Barry, Ronald A ^a   Hinrichs, David J ^a  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL VACCINE; CD8 ANTIGEN; EPITOPE; H2 ANTIGEN; LISTERIOLYSIN; RECOMBINANT VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM MUTANT; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNIZATION; LISTERIA MONOCYTOGENES; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL;

EID: 0032892551     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.1.253-258.1999     Document Type: Article

References (41)

1. Baldridge, J. R., R. A. Barry, and D. J. Hinrichs. 1990. Expression of systemic protection and delayed-type hypersensitivity to Lisieria monocytogenes is mediated by different T-cell subsets. Infect. Immun. 58:654-658.
2. Barry, R. A., H. G. A. Bouwer, D. A. Portnoy, and D. J. Hinrichs. 1992 Pathogenicity and immunogenicity of Listeria monocytogenes small-plaque mutants defective for intracellular growth and cell-to-cell spread. Infect. Immun. 60:1625-1632.
3. Barry, R. A., and D. J. Hinrichs. 1982. Enhanced adoptive transfer of immunity to Listeria monocytogenes after in vitro culture of murine spleen cells with concanavalin A. Infect. Immun. 35:560-565.
4. Bishop, D. K., and D. J. Hinrichs. 1987. Adoptive transfer of immunity to Listeria monocytogenes. The influence of in vitro stimulation on lymphocyte subset requirements. J. Immunol. 139:2005-2009.
5. Bouwer, H. G. A., R. A. Barry, and D. J. Hinrichs. 1997. Acquired immunity to an intracellular pathogen: immunologic recognition of L. monocytogenes-infected cells. Immunol. Rev. 158:137-146.
6. Bouwer, H. G. A., B. L. Gibbins, S. Jones, and D. J. Hinrichs. 1994. Antilisterial immunity includes specificity to listeriolysin O (LLO) and non-LLO-derived determinants. Infect. Immun. 62:1039-1045.
7. Bouwer, H. G. A., and D. J. Hinrichs. 1996. Cytotoxic-T-lymphocyte responses to epitopes of listeriolysin O and p60 following infection with Listeria monocytogenes. Infect. Immun. 64:2515-2522.
8. Bouwer, H. G. A., K. F. Lindahl, J. R. Baldridge, C. R. Wagner, R. A. Barry, and D. J. Hinrichs. 1994. An H2-T MHC class Ib molecule presents Listeria monocytogenes-derived antigen to immune CD8+ cytotoxic T cells. J. Immunol. 152:5352-5360.
9. Bouwer, H. G. A., M. Moors, and D. J. Hinrichs. 1996. Elimination of the listeriolysin O-directed immune response by conservative alteration of the immunodominant listeriolysin O amino acid 91 to 99 epitope. Infect. Immun. 64:3728-3735.
10. Bouwer, H. G. A., C. S. Nelson, B. L. Gibbins, D. A. Portnoy, and D. J. Hinrichs. 1992. Listeriolysin O is a target of the immune response to Listeria monocytogenes. J Exp. Med. 175:1467-1471.
11. Busch, D. H., and E. G. Pamer. 1998. MHC class I/peptide stability: implications for immunodominance, in vitro proliferation, and diversity of responding CTL. J. Immunol. 160:4441-4448.
12. Cossart, P., and J. Mengaud. 1989. Listeria monocytogenes. A model system for the molecular study of intracellular parasitism. Mol. Biol. Med. 6:463-474.
13. Cossart, P., M. F. Vicente, J. Mengaud, F. Baquero, J. C. Perez-Diaz, and P. Berche. 1989. Listeriolysin O is essential for virulence of Listeria monocytogenes: direct evidence obtained by gene complementation. Infect. Immun. 57:3629-3636.
14. Ertl, H. C., and Z. Xiang. 1996. Novel vaccine approaches. J. Immunol. 156:3579-3582.
15. Frankel, F. R., S. Hedge, J. Lieberman, and Y. Paterson. 1998. Induction of cell mediated immune responses to human immunodeficiency virus type 1 Gag protein by using Listeria monocytogenes as a live vaccine vector. J. Immunol. 155:4775-4782.
16. Harty, J. T., and M. J. Bevan. 1992. CD8+ T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo. J. Exp. Med. 175:1531-1538.
17. Harty, J. T., and M. J. Bevan. 1996. CD8 T-cell recognition of macrophages and hepatocytes results in immunity to Listeria monocytogenes. Infect. Immun. 64:3632-3640.
18. Harty, J. T., and E. G. Pamer. 1995. CD8 T lymphocytes specific for the secreted p60 antigen protect against Listeria monocytogenes infection. J. Immunol. 154:4642-4650.
19. Hayder, H., and A. Mullbacher. 1996. Molecular basis of immune evasion strategies by adenovirus. Immunol. Cell Biol. 74:504-512.
20. Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59.
21. Ikonomidis, G., Y. Paterson, F. J. Kos, and D. A. Portnoy. 1994. Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes. J. Exp. Med. 180:2209-2218.
22. Jensen, E. R., H. Shen, F. O. Wettstein, R. Ahmed, and J. F. Miller. 1997. Recombinant Listeria monocytogenes as a live vaccine vehicle and a probe for studying cell-mediated immunity. Immunol. Rev. 158:147-157.
23. Kay, M. A., L. Meuse, A. M. Gown, P. Linsley, D. Hollenbaugh, A. Aruffo, H. D. Ochs, and C. B. Wilson. 1997. Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver. Proc. Natl. Acad. Sci. USA 94:4686-4691.
24. Kundig, T. M., C. P. Kalberer, H. Hengartner, and R. M. Zinkernagel. 1993. Vaccination with two different vaccinia recombinant viruses: long-term inhibition of secondary vaccination. Vaccine 11:1154-1158.
25. Mackaness, G. B. 1962. Cellular resistance to infection. J. Exp. Med. 116: 381-406.
26. Mielke, M. E., C. Peters, and H. Hahn. 1998. Cytokines in the induction and expression of T-cell mediated granuloma formation and protection in the murine model of listeriosis. Immunol. Rev. 158:79-93.
27. Miller, M. A., M. J. Skeen, and H. K. Ziegler. 1995. Nonviable bacterial antigens administered with IL-12 generate antigen-specific T cell responses and protective immunity against Listeria monocytogenes. J. Immunol. 155: 4817-4828.
28. Mocci, S., S. A. Dalrymple, R. Nishinakamura, and R. Murray. 1998. The cytokine stew and innate resistance to L. monocytogenes. Immunol. Rev. 158:107-114.
29. Mosier, D. E., R. J. Gulizia, P. D. MacIsaac, L. Corey, and P. D. Greenberg. 1993. Resistance to human immunodeficiency virus infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160. Proc. Natl. Acad. Sci. USA 90:2443-2447.
30. Murata, K., A. Garcia-Sastre, M. Tsuji, M. Rodrigues, O. Rodriguez, J. R. Rodriguez, R. S. Nussenzweig, P. Palese, M. Esteban, and F. Zavala. 1996. Characterization of in vivo primary and secondary CD8+ T cell responses induced by recombinant influenza and vaccinia viruses. Cell. Immunol. 173: 96-107.
31. North, R. J., P. Berche, and M. F. Newborg. 1981. Immunologic consequences of antibiotic-induced abridgement of bacterial infection: effect on generation and loss of protective T cells and level of immunologic memory. J. Immunol. 127:342-346.
32. Pamer, E. G. 1994. Direct sequence identification and kinetic analysis of an MHC class I-restricted Listeria monocytogenes CTL epitope. J. Immunol. 152:686-694.
33. Pamer, E. G., J. T. Harty, and M. J. Bevan. 1991. Precise prediction of a dominant class 1 MHC-restricted epitope of Listeria monocytogenes. Nature 353:852-855.
34. Pan, Z.-K., G. Ikonomidis, A. Lazenby, D. Pardoll, and Y. Paterson. 1995. A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours. Nat. Med. 1:471-477.
35. Portnoy, D. A., T. Chakraborty, W. Goebel, and P. Cossart. 1992. Molecular determinants of Listeria monocytogenes pathogenesis. Infect. Immun. 60: 1263-1267.
36. Portnoy, D. A., P. S. Jacks, and D. J. Hinrichs. 1988. Role of hemolysin for the intracellular growth of Listeria monocytogenes. J. Exp. Med. 167:1459-1471.
37. Scaria, A., J. A. St George, R. J. Gregory, R. J. Noelle, S. C. Wadsworth, A. E. Smith, and J. M. Kaplan. 1997. Antibody to CD40 ligand inhibits both humoral and cellular immune responses to adenoviral vectors and facilitates repeated administration to mouse airway. Gene Ther. 4:611-617.
38. Schafer, R., D. A. Portnoy, S. A. Brassell, and Y. Paterson. 1992. Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine. J. Immunol. 149:53-59.
39. Shen, H., M. K. Slifka, M. Matloubian, E. R. Jensen, R. Ahmed, and J. F. Miller. 1995. Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell mediated immunity. Proc. Natl. Acad. Sci. USA 92:3987-3991.
40. Taswell, C. 1981. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126:1614-1619.
41. Xiang, Z. Q., Y. Yang, J. M. Wilson, and H. C. Ertl. 1996. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 219:220-227.